High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy

AIDS. 1998 Dec 3;12(17):2358-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • DNA, Viral
  • Dideoxynucleosides / therapeutic use
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1* / genetics
  • Humans
  • Indinavir / therapeutic use
  • Leukocytes, Mononuclear / virology
  • Male
  • Middle Aged
  • RNA, Viral
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Ritonavir / therapeutic use
  • Viral Load*

Substances

  • Anti-HIV Agents
  • DNA, Viral
  • Dideoxynucleosides
  • HIV Protease Inhibitors
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Indinavir
  • Ritonavir